PULMATRIX, INC. Revenues
PULMATRIX, INC. (PULM) reported Revenues of $7.91 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-26.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2020-03-26
- PULMATRIX, INC. revenues for the quarter ending 2019-12-31 was $1.69M, a 1001.31% increase year-over-year.
- PULMATRIX, INC. revenues for the quarter ending 2019-09-30 was $1.41M.
- PULMATRIX, INC. revenues for the quarter ending 2019-06-30 was $4.82M.
- PULMATRIX, INC. revenues for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- PULMATRIX, INC. revenues for fiscal 2019 was $7.91M, a 5069.93% increase from fiscal 2018.
- PULMATRIX, INC. revenues for fiscal 2018 was $153.00K, a 54.33% decline from fiscal 2017.
- PULMATRIX, INC. revenues for fiscal 2017 was $335.00K, a 59.88% decline from fiscal 2016.
- PULMATRIX, INC. revenues for fiscal 2016 was $835.00K, a 30.47% decline from fiscal 2015.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|---|
| 2019-12-31 | $1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $3.09M derived: sum of 2 quarters · filed 2020-03-26 | $7.91M derived: sum of 3 quarters · filed 2020-03-26 | $7.91M 10-K · filed 2020-03-26 | |
| 2019-09-30 | $1.41M 10-Q · filed 2019-11-01 | $6.22M derived: sum of 2 quarters · filed 2019-11-01 | $6.22M 10-Q · filed 2019-11-01 | $6.38M derived: sum of 4 quarters · filed 2020-03-26 | |
| 2019-06-30 | $4.82M 10-Q · filed 2019-08-05 | $4.82M 10-Q · filed 2019-08-05 | $4.97M derived: sum of 3 quarters · filed 2020-03-26 | $4.97M derived: sum of 4 quarters · filed 2020-03-26 | |
| 2019-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2020-03-26 | $153.00K derived: sum of 2 quarters · filed 2020-03-26 | $153.00K derived: sum of 3 quarters · filed 2020-03-26 | $153.00K derived: sum of 4 quarters · filed 2020-03-26 | |
| 2018-12-31 | $153.00K 10-Q · filed 2019-05-15 | $153.00K derived: sum of 2 quarters · filed 2019-11-01 | $153.00K derived: sum of 3 quarters · filed 2019-11-01 | $153.00K 10-K · filed 2020-03-26 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $0.00 derived: sum of 2 quarters · filed 2019-11-01 | $153.00K 10-Q · filed 2019-11-01 | $153.00K derived: sum of 4 quarters · filed 2019-11-01 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-05 | $153.00K 10-Q · filed 2019-08-05 | $153.00K derived: sum of 3 quarters · filed 2019-08-05 | $488.00K derived: sum of 4 quarters · filed 2019-08-05 | |
| 2018-03-31 | $153.00K 10-Q · filed 2018-05-11 | $153.00K derived: sum of 2 quarters · filed 2019-02-19 | $488.00K derived: sum of 3 quarters · filed 2019-02-19 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $335.00K derived: sum of 2 quarters · filed 2019-02-19 | $335.00K 10-K · filed 2019-02-19 | ||
| 2017-09-30 | $335.00K 10-Q · filed 2018-11-14 | $335.00K 10-Q · filed 2018-11-14 | |||
| 2016-12-31 | $117.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $178.00K derived: sum of 2 quarters · filed 2018-03-13 | $438.00K derived: sum of 3 quarters · filed 2018-03-13 | $835.00K 10-K · filed 2018-03-13 | |
| 2016-09-30 | $61.00K 10-Q · filed 2017-11-09 | $321.00K derived: sum of 2 quarters · filed 2017-11-09 | $718.00K 10-Q · filed 2017-11-09 | $992.00K derived: sum of 4 quarters · filed 2017-11-09 | |
| 2016-06-30 | $260.00K 10-Q · filed 2017-08-04 | $656.00K 10-Q · filed 2017-08-04 | $931.00K derived: sum of 3 quarters · filed 2017-08-04 | $1.58M derived: sum of 4 quarters · filed 2017-08-04 | |
| 2016-03-31 | $396.00K 10-Q · filed 2017-05-05 | $671.00K derived: sum of 2 quarters · filed 2017-05-05 | $1.32M derived: sum of 3 quarters · filed 2017-05-05 | $1.49M derived: sum of 4 quarters · filed 2017-05-05 | |
| 2015-12-31 | $275.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $926.00K derived: sum of 2 quarters · filed 2017-03-10 | $1.10M derived: sum of 3 quarters · filed 2017-03-10 | $1.20M 10-K · filed 2017-03-10 | |
| 2015-09-30 | $651.00K 10-Q · filed 2016-11-04 | $821.00K derived: sum of 2 quarters · filed 2016-11-04 | $926.00K 10-Q · filed 2016-11-04 | $926.00K derived: sum of 4 quarters · filed 2016-11-04 | |
| 2015-06-30 | $170.00K 10-Q · filed 2016-08-04 | $275.00K 10-Q · filed 2016-08-04 | $275.00K derived: sum of 3 quarters · filed 2016-08-04 | $305.00K derived: sum of 4 quarters · filed 2016-08-04 | |
| 2015-03-31 | $105.00K 10-Q · filed 2016-05-05 | $105.00K derived: sum of 2 quarters · filed 2016-05-05 | $135.00K derived: sum of 3 quarters · filed 2016-05-05 | $0.00 10-K · filed 2015-06-10 | |
| 2014-12-31 | $0.00 10-Q · filed 2015-02-13 | $30.00K derived: sum of 2 quarters · filed 2015-11-12 | $0.00 10-Q · filed 2015-02-13 | $352.00K 10-K · filed 2016-03-10 | |
| 2014-09-30 | $30.00K 10-Q · filed 2015-11-12 | $0.00 10-Q · filed 2014-11-13 | $0.00 10-Q · filed 2014-11-13 | $38.00K 10-Q · filed 2015-11-12 | $30.00K derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-14 | $8.00K 10-Q · filed 2015-08-14 | $0.00 derived: sum of 3 quarters · filed 2015-06-10 | $0.00 derived: sum of 4 quarters · filed 2015-06-10 | |
| 2014-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-10 | $0.00 derived: sum of 2 quarters · filed 2015-06-10 | $0.00 derived: sum of 3 quarters · filed 2015-06-10 | $0.00 10-K · filed 2015-06-10 | |
| 2013-12-31 | $0.00 10-Q · filed 2015-02-13 | $0.00 derived: sum of 2 quarters · filed 2015-02-13 | $0.00 10-Q · filed 2015-02-13 | ||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-13 | $0.00 10-Q · filed 2014-11-13 | |||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |